Skip to content

Initiative in LYon for Lung cAncer Screening Development - Prevalence Study

Initiative in LYon for Lung cAncer Screening Development - Prevalence Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04240418
Acronym
ILYAD1
Enrollment
4595
Registered
2020-01-27
Start date
2020-10-31
Completion date
2021-01-14
Last updated
2021-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer, Screening

Brief summary

Screening at-risk subjects with low-dose computed tomography (CT) efficiently reduces lung cancer specific mortality. However screening efficiency relies on the at-risk population's criteria definition and its participation rate to the screening. In France, there are concerns regarding the participation rates to national cancer screening that are quite low (around 50% and 32% of the eligible population for breast cancer and colorectal cancer respectively). Before organizing national lung cancer screening it is then crucial to determine the factors impacting the at-risk subjects willingness to participate in lung cancer screening. The Lyon University Hospital is the second biggest hospital in France with more than 23,000 employees distributed among more than 160 professions representing every level of education or working conditions. Its population is heterogeneous and wide enough to perform a prevalence study assessing the willingness to participate among the at-risk population. ILYAD is a prospective study performed by anonymous questionnaires that will be submitted to the 23,000 employees of the Lyon University Hospital. The study main objective is to evaluate the at-risk population presence in the Lyon University Hospital population, as defined by NELSON criteria and selection criteria for lung cancer screening (PLCOm2012 scoring), and its willingness to participate to a lung-cancer screening with low-dose CT. This might help further efficient national lung cancer screening campaign organization.

Interventions

OTHERSurvey

The objective is to evaluate the eligibility of the responders, as defined by NELSON criteria and PLCOm2012 scoring, and their willingness to participate to a lung-cancer screening with low-dose computed tomography.

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Aged ≥ 18 years old * Employee from the Lyon University Hospital (receiving salary from the Lyon University Hospital) * Person who has willingness to respond the survey

Exclusion criteria

* Employees not hired by the Lyon University Hospital * Employees who have not willingness to participate in the survey

Design outcomes

Primary

MeasureTime frameDescription
Number of employees belonging to the at-risk population for lung cancer and consequently eligible to lung cancer screening.Day 0 (at inclusion)High-risk ever-smokers are defined as ever-smokers aged 55-74 years old, having smoked \>15 cigarettes per day for \>25 years or \>10 cigarettes for \>30 years and with ≤15 years since cessation for quitters.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026